Original Article Endocrinology/Diabetes/Metabolism Nuclear Medicine Trauma
Prone positioning and medication adherence in cancer survivors: A quality-improvement audit

Prone positioning and medication adherence in cancer survivors: A quality-improvement audit

Authors

Lucas Ibrahim

Lucas Ibrahim

St Thomas' Hospital, Sao Tome and Principe

Adam Moreau

Adam Moreau

King Fahad Medical City, Antarctica

Corresponding

Published

March 15, 2025

Paper ID

PAP-000214

Status

Published

DOI

10.65712/tmj.test000472

Prone positioning and medication adherence in cancer survivors: A quality-improvement audit

Advance Services

Create Content

Video • Presentation • Poster

From $97.00 per format

Abstract

Background: Earlier studies of prone positioning were small or single-centre. Methods: Eligible participants were cancer survivors. Results: The adjusted odds ratio was 0.48 (95% CI 0.28 to 0.95). Serious adverse events were rare and similar between groups. Conclusion: Implementation will depend on staffing, cost and local protocols.

Introduction

The cost of medication adherence to health systems is substantial. Practice around prone positioning varies widely between centres.

Practice around prone positioning varies widely between centres. Earlier studies of prone positioning were small or single-centre.

Materials and Methods

The primary outcome was medication adherence, assessed blind to allocation. Eligible participants were cancer survivors.

Missing data were handled with multiple imputation. Analyses were adjusted for age, sex and baseline severity. Eligible participants were cancer survivors.

Results

The adjusted odds ratio was 0.51 (95% CI 0.33 to 0.81). 1247 participants were included (median age 39 years). 1913 participants were included (median age 58 years).

Effects were consistent across prespecified subgroups. 4342 participants were included (median age 38 years).

GroupnEventsRate %
Female51912023.3
Intervention4063929.7
Centre A24211518.4
Control4121127.3
Control506617.5
Intervention5591010.4
Age < 6580711921.4
TABLE 1: Baseline characteristics
Values are n (%) unless stated otherwise.
Figure 1
FIGURE 1: Trend in medication adherence
Shown for cancer survivors; error bars are 95% confidence intervals.

364 participants were included (median age 48 years). The adjusted odds ratio was 0.60 (95% CI 0.32 to 0.69).

medication adherence occurred in 15% of the intervention group versus 12% of controls. 138 participants were included (median age 59 years). 4350 participants were included (median age 51 years). medication adherence occurred in 22% of the intervention group versus 23% of controls.

Discussion

Implementation will depend on staffing, cost and local protocols. Future work should test prone positioning in a pragmatic multicentre trial.

Residual confounding cannot be excluded. Future work should test prone positioning in a pragmatic multicentre trial. Strengths include the sample size and blinded outcome assessment.

Implementation will depend on staffing, cost and local protocols. Residual confounding cannot be excluded. Strengths include the sample size and blinded outcome assessment.

Future work should test prone positioning in a pragmatic multicentre trial. Residual confounding cannot be excluded. Implementation will depend on staffing, cost and local protocols.

Future work should test prone positioning in a pragmatic multicentre trial. These findings suggest that prone positioning is associated with better medication adherence in cancer survivors.

Conclusions

Prone positioning may be offered for cancer survivors to improve medication adherence.

References

1. Volkov O, Herrera D, et al. Early enteral nutrition and patient satisfaction. Lancet. 2023;321(11):511-1684.

2. Mueller P, Mensah I, et al. Tranexamic acid and patient satisfaction. BMJ. 2013;105(7):572-912.

3. Mueller H, Haddad I, et al. SGLT2 inhibitors and ventilator-free days. N Engl J Med. 2021;242(6):74-1345.

4. Silva T, Tanaka E, et al. Frailty screening and glycaemic control. Eur Heart J. 2022;224(4):869-1181.

5. Silva Y, Nakamura E, et al. Early enteral nutrition and length of stay. N Engl J Med. 2013;12(8):210-1647.

6. Rossi I, Farouk H, et al. Machine-learning triage and post-operative delirium. Ann Intern Med. 2018;308(11):74-1783.

7. Kim C, Volkov Z, et al. Tranexamic acid and post-operative delirium. Crit Care Med. 2025;15(2):140-1486.

Appendices

The statistical analysis plan is in the online supplement.